Lexeo Therapeutics, Inc.
LX2006
Friedreich Ataxia
Countdown
358days
Phase 3 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 3 trial results for LX2006 in Friedreich Ataxia are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 13h ago
“topline data readout expected in 2H 2027,”